46 patents currently held
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Apr 2031. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Apr 2031
Next term end
17
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2031 · High confidence
Also notable
Ends Apr 2034 · High confidence
Also notable
Ends Aug 2034 · High confidence
Also notable
Ends Sep 2035 · High confidence
Also notable
Ends Apr 2035 · High confidence
Also notable
Ends Mar 2034 · High confidence
Also notable
Ends Jul 2037 · High confidence
Also notable
Ends May 2037 · High confidence
Transcatheter Mitral Valve Prosthesis
US 9,248,014
Cited by 404 later US patents, top 1% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Methods and Apparatus for Loading a Prosthesis onto a Delivery System
US 9,345,573
Cited by 271 later US patents, top 1% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Sequentially Deployed Transcatheter Mitral Valve Prosthesis
US 9,308,087
Cited by 404 later US patents, top 1% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Methods and Apparatus for Engaging a Valve Prosthesis with Tissue
US 9,554,897
Cited by 618 later US patents, top 1% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
Methods and Apparatus for Delivering a Prosthetic Valve to a Beating Heart
US 9,572,665
Cited by 229 later US patents, top 1% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
Prosthetic Valve with Anti-Pivoting Mechanism
US 10,583,002
Cited by 469 later US patents, top 1% of utility patents granted in 2020 in our data. Protection runs to 2034.
Prosthetic Valve for Avoiding Obstruction of Outflow
US 10,433,952
Cited by 136 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2037.
Transseptal Delivery System
US 10,631,984
Cited by 94 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2037.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 11, 2026The maintenance fee for Methods and Apparatus for Loading a Prosthesis onto a Delivery System (US 10,314,705) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
- 1 fee due Jan 30, 2027The maintenance fee for Methods and Apparatus for Engaging a Valve Prosthesis with Tissue (US 10,363,133) comes due Jan 30, 2027. Unpaid by Jul 30, 2027, it lapses early.
- 2 fees due Feb 20 to 28, 2027 · next Feb 20
- 4 fees due Apr 8 to 24, 2027 · next Apr 8
- 2 fees due Jul 21 to 26, 2027 · next Jul 21
- 1 fee due Aug 2, 2027The maintenance fee for Transcatheter Mitral Valve Prosthesis (US 9,248,014) comes due Aug 2, 2027. Unpaid by Feb 2, 2028, it lapses early.
- 2 fees due Sep 10 to 19, 2027 · next Sep 10
- 2 fees due Oct 12 to 28, 2027 · next Oct 12
Recent changes
- 1 of the patents on this record was granted since Aug 21, 2026
What they patent
The largest of its 17 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,241,790 | Transcatheter Mitral Valve Prosthesis In force · High confidence | In force | High confidence | |
| US 9,248,014 | Transcatheter Mitral Valve Prosthesis In force · High confidence | In force | High confidence | |
| US 10,449,042 | Transcatheter Mitral Valve Prosthesis In force · High confidence | In force | High confidence | |
| US 11,432,924 | Transcatheter Mitral Valve Prosthesis In force · High confidence | In force | High confidence | |
| US 9,770,329 | Transcatheter Mitral Valve Prosthesis In force · High confidence | In force | High confidence | |
| US 8,579,964 | Transcatheter Mitral Valve Prosthesis In force · High confidence | In force | High confidence | |
| US 11,419,720 | Transcatheter Mitral Valve Prosthesis In force · Medium confidence | In force | Medium confidence | |
| US 12,053,369 | Sequentially Deployed Transcatheter Mitral Valve Prosthesis In force · Medium confidence | In force | Medium confidence | |
| US 9,713,529 | Sequentially Deployed Transcatheter Mitral Valve Prosthesis In force · High confidence | In force | High confidence | |
| US 12,138,159 | Methods and Apparatus for Engaging a Valve Prosthesis with Tissue In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 46: 3 patents in force now held by others · 8 patents ended · 7 applications pending · 18 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.